Sign In
Free Newsletter
Lupin Pharma expands Baltimore office
//June 25, 2013
Lupin Pharmaceuticals Inc., a manufacturer of generic drugs headquartered in Mumbai, India, has renewed a lease for its North American sales and marketing division at 111 S. Calvert St., the Baltimore office of Cushman & Wakefield announced.
Lupin, one of the fastest-growing pharmaceutical companies in the U.S., will double its space, taking 34,432 square feet on two full floors.
The distinctive, 28-story Harborplace Tower, which overlooks the Harborplace pavilions at the Inner Harbor, is one of downtown Baltimore’s landmark office buildings.
Like Harborplace, it is owned by Chicago-based General Growth Properties Inc.
Lupin Pharmaceuticals was represented by Bruce Matthai of Cassidy Turley. C&W’s Tim Jackson represented the landlord, GGP.
